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Fig. 1. Different types of T helper (Th) subsets. The cytokine pro-
file which is responsible for the differentiation from activated na-
ïve T cells into the three distinct Th subsets is shown. The main 
effector cytokines of and functions for each Th subset is shown.
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T helper (Th) 17 cells have recently been described as a third 
subset of T helper cells, and have provided new insights into the 
mechanisms that are important in the development of auto-
immune diseases and the immune responses that are essential for 
effective antimicrobial host defense. Both protective and harmful 
effects of Th17 responses during infection have been described. 
In general, Th17 responses are critical for mucosal and epithelial 
host defense against extracellular bacteria and fungi. However, 
recent studies have reported that Th17 responses can also 
contribute to viral persistence and chronic inflammation 
associated with parasitic infection. It has become evident that the 
type of microorganisms and the setting in which they trigger the 
Th17 response determines the outcome of the delicate balance 
that exists between Th17 induced protection and immuno-
pathogenesis. [BMB reports 2009; 42(12): 776-787]
INTRODUCTION
Mosmann and Coffman have introduced the concept of different 
sets of T helper (Th) cells, namely Th1 cells and Th2 cells (1). Th1 
cells are characterized by the production of interferon-γ, which is 
essential for the defense against intracellular pathogens. Th2 
cells are characterized by the production of interleukin (IL)-4 and 
are important in the host defense against parasitic infections. 
Recently, a new subset of T helper cells called Th17 cells has 
been described and these cells are characterized by the pro-
duction of IL-17 (2), which is important for neutrophil recruit-
ment and host defense against extracellular bacteria and fungi. 
Th17 cells produce a distinct cytokine profile, namely IL-17A 
(IL-17), IL-17F, IL-21 and IL-22. Like Th1 and Th2 cells, the devel-
opment of Th17 cells from naïve T cells is dependent on antigen 
presentation by professional antigen presenting cells, co-stim-
ulatory stimulation, and a specific cytokine milieu. In summary, 
the cytokines IL-1β, IL-6, TGFβ have been reported to induce the 
development of Th17 cells and IL-23 has been reported to be im-
portant for the maintenance of Th17 cells, whereas IL-12 is im-
portant for Th1 differentiation and IL-4 drives activated naive T 
cells towards Th2 cells (3) (Fig. 1). It is important to mention that 
the cytokine IL-12 is composed of the subunits IL-12p40 and 
IL-12p35, and the cytokine IL-23 is composed of IL-12p40 and 
IL-23p19. Therefore IL-23p19 deficient mice are generally used 
as a model to study the role of IL-23, and IL-12p35 deficient mice 
are used to investigate IL-12 dependent mechanisms of disease. 
The functions of Th17 cells, called Th17 responses, in infectious 
diseases and autoimmune diseases have only recently started to 
be elucidated. It has become apparent that Th17 responses are 
associated with chronic inflammation and autoimmune diseases 
such as multiple sclerosis and rheumatoid arthritis (4). Further-
more, Th17 responses have been shown to be important for the 
host defense against many microorganisms, although they can al-
so contribute to immunopathology during infection. In this re-
view we will provide an overview of the rapidly extending liter-
ature that has investigated the role of Th17 responses in relation 
to viral, bacterial, fungal and parasitic infections.
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Th17 responses and infections in STAT3 deficient patients
STAT3 deficiency in humans, demonstrated to be the cause 
hyperIgE syndrome, has provided crucial insights in the role of 
Th17 responses in the setting of antimicrobial host defense. 
STAT3 deficient patients suffer from S. aureus skin and pulmo-
nary infections and mucocuteneous candidiasis (5). The cause of 
these complications has been linked to a defective Th17 re-
sponse against C. albicans and gram positive bacteria, such as S. 
aureus and S. pyogenes (6). Intriguingly, defective Th17 re-
sponses were also seen with mitogenic stimulation of CD4 T 
helper cells from these patients, suggesting a severe defect in 
mounting an optimal Th17 response against many stimuli. These 
observations provide strong evidence that Th17 responses are 
needed to control fungal colonization at the mucosal level, and 
play an important role in host defense against extracellular bac-
teria, especially S. aureus, in the lung and skin. 
Fungal infections
Candida 
Involvement of Th17 responses in protective antifungal host 
defense was first demonstrated in IL-17RA deficient mice that 
showed increased susceptibility to disseminated C. albicans in-
fection (7). In addition, a model for oropharyngeal candidiasis 
in mice showed that IL-23p19 or IL-17 deficiency resulted in 
severe oropharyngeal candidiasis, while mice deficient for IL- 
12p35 did not show this (8). However, negative effects of Th17 
mediated inflammatory responses to intragastric C. albicans 
and intranasal Aspergillus fumingatus infection in mice have 
also been reported. IL-23p19 deficiency was shown to reduce 
fungal burden and IL-17 inhibited Th1 responses to C. albicans 
(9). Furthermore, mice with defects in Toll IL1R8 (TIR8), a ne-
gative regulator of Th17 responses, showed higher suscepti-
bility to Candida and Aspergillus and more immunopathology 
(10). Differences in the animal model, Candida strains and mouse 
strains could account for these contradictory observations. 
However, patients with impaired Candida specific Th17 
responses such as patients with hyper IgE syndrome or chronic 
mucocutaneous candidiasis (CMC), are highly susceptibility to 
mucosal C. albicans infections (5, 11). These observations 
strongly indicate that Th17 responses are important for human 
anti-Candida mucosal host defense. Th17 induction in re-
sponse to Candida infection is strongly dependent on C type 
lectin receptors (CLRs), since it has been shown that the CLR: 
mannose receptor, dectin-1 and dectin-2 are important in the 
IL-17 production in response to Candida (12-14). Furthermore, 
dectin-1 and dectin-2 signal through the Syk-CARD9 pathway, 
and CARD9 was shown to be involved in Candida-induced 
Th17 responses (13). Recently, it has been reported that pa-
tients with genetic defects in dectin-1 or CARD9 suffer from 
chronic oychomycosis and mucosal fungal infection (15, 16). 
Both dectin-1 and CARD9 deficiency was shown to result in 
deficient fungal induced IL-17 responses. These data further 
strengthen the crucial role of Th17 cells in human antifungal 
mucosal defense. 
Other fungi
Patients with chronic granulomatous disease (CGD) lack NADPH 
oxidase activity and do not generate reactive oxygen species, 
which results in recurrent bacterial and fungal infections, espe-
cially fungal infections with Aspergillus. It has been reported that 
in the setting of deficient reactive oxygen species generation in 
a mouse model of CGD, the tryptophan metabolism in mice is 
deficient, which eventually resulted in increased IL-17 responses 
(17). These increased IL-17 responses were suggested to be 
detrimental to the host when CGD mice were infected with 
Aspergillus. It has been suggested that the IL-17 pathway also 
plays a role in Pneumocystis carinii infections. Stimulation of 
alveolar macrophages with Pneumocystis carinii induces IL-23 
mRNA. Furthermore, neutralization of IL-23 or IL-17 increased 
disease severity during P. carinii infection in WT mice (18). 
Another important fungal pathogen is Cryptococcus neoformans, 
which is associated with HIV infection and causes lethal fungal 
meningoencephalitis in patients suffering from AIDS. Mice de-
ficient of IL-12p40 show much higher mortality and had im-
paired IL-17 expression when compared to IL-12p35 deficient 
mice (19). This indicates a role for IL-23 and thus Th17 re-
sponses in protection against C. neoformans infection. Another 
study that investigated the role of the Th17 response in anti-
fungal host defense reported that in a mice model of Paraco-
ccidioides braziliensis infection, TLR2 deficiency resulted in 
increased Th17 responses which were associated with pro-
tection (20). Overall, these data indicate that Th17 responses 
can be induced by fungi and that the IL-17 pathway plays an 
important role in the protective antifungal host defense.
Th17 responses in bacterial infections
Borrelia
One of the first studies that reported pathogen specific induced 
IL-17 production showed that Borrelia burgdorferi and Myco-
bacterium bovis BCG lipopetides were able to induce IL-17 in 
addition to IFNγ in CD4 positive T helper cells (21). Further-
more, it was shown that these responses were dependent on 
antigen presentation (21). Another study reported that B. burg-
dorferi triggers bone marrow derived DC’s to produce IL-23, 
causing stimulation of IL-17 producing T-cells (22). Codolo et 
al. presented that B. burgdorferi neutrophil-activating protein A 
(NapA) is capable of generating increased IL-6, IL-1β, IL-23, 
and TGF-β expression by cells of the innate immune system, 
thereby inducing Th17 responses in human synovial fluid (23). 
Notably, in an animal model of Borrelia-induced destructive 
arthritis, anti-IL-17 and anti-IL-17R treatment resulted in pre-
vention of severe destructive arthritis (24). In addition, it was 
shown that IL-23, which is a survival factor for Th17 cells, was 
associated with Lyme arthritis, and depletion of IL-23p19 or 
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blockade of IL-23 resulted in the absence of Borrelia induced 
arthritis in mice (25). These studies provide evidence that 
while Th17 effector functions are likely to be involved in the 
host defense against Borrelia spp., they also play an important 
role in mediating the strong immunopathology associated with 
chronic Borrelia infection.
Helicobacter pylori
IL-17 has been shown to be increased in H. pylori-infected 
gastric mucosa and stimulated the synthesis of IL-8 which is a 
strong chemoattractant for neutrophils (26). Another study pro-
vided evidence that STAT3 activation in lamina propria mono-
nuclear cells could lead to sustained IL-17 production, result-
ing in persistent inflammation (27). In an experimental mouse 
model, IL-17 neutralization resulted in an increased Th1 re-
sponse with elevated IL-12, TNF-α and IFN-γ mRNAs levels, 
while replenishing IL-17 showed reduction of the Th1 re-
sponse (28). This underscores that counter-regulation between 
Th1 and Th17 responses is present during infection. As with 
many other infections, it remains to be determined which re-
sponse is protective for host defense against H. pylori and 
which response will lead to persistent infection that could be 
detrimental to the host. Notably, it has been shown in a recent 
publication that IL-17RA signaling regulates gastric B cell re-
cruitment (29). This indicates that IL-17 has an important role 
in the orchestration of immune cells such as neutrophils and B 
cells at the site of infection during H. pylori infection. 
Klebsiella pneumoniae
IL-17 deficient mice suffer from lethal K. pneumoniae infection 
in contrast to control mice (30). In addition, overexpression of 
IL-17 leads to increased IL-1β, TNF-α and MIP-2 and G-CSF, 
which results in higher leukocyte numbers and increased clear-
ance of infection (30). Experimental K. pneumoniae infection in 
mice was reported to induce IL-23p19 and subsequently IL-17 
production (31). Furthermore, the importance of the Th17 cyto-
kines for protection against K. pneumonia infection was shown 
in mice deficient in IL-12p40, IL-23p19 or IL-17R, which suffer 
from higher susceptibility and mortality (32). Furthermore, IL-17 
administration was able to restore the normal host defense 
against K. pneumoniae in IL-23 deficient mice (32). Both IL-17 
and IL-22 were shown to be crucial for protective local host de-
fense against K. pneumonia. However, only IL-22 was crucial for 
defense against transepithelial damage, since in contrast to IL-17, 
IL-22 was able to enhance repair of transepithelial resistance. 
Interestingly, it was shown that blocking IL-22 in mice infected 
with K. pneumonia resulted in 100% mortality within one day, 
which was significantly earlier than control mice or IL-17 defi-
cient mice. Furthermore, IL-22 blockade resulted in increased 
dissemination of bacteria in both control mice and IL-17 deficient 
mice. These data argue that IL-22 plays a more important role 
than IL-17 in mucosal host defense against K. pneumonia. A re-
cent study has reported that lipocalin-2 is important for mucosal 
host defense against K. pneumonia. Although IL-17 can induce 
Lcn2 in vitro, it was not necessary for in vivo induction (33, 34). 
IL-22 is also able to induce Lcn2 in vitro (33). However, to what 
extend IL-22 plays a role in the induction of Lcn2 in vivo remains 
to be determined. In conclusion, Th17 responses provide pro-
tective host defense against K. pneumonia.
Citrobacter rodentium
Infection of IL-23p19 deficient mice with Citrobacter rodentium 
showed reduced survival rates due to increased bacterial dissemi-
nation as a result of impaired Th17 responses (35). Also, a role for 
IL-17A and IL-17F induced β-defensin expression in the defense 
against C. rodentium has been described (36). In addition, by using 
the C. rodentium as a mouse model for human intestinal infection, 
Zheng et al. hypothesized that the Th17 cytokine IL-22 also plays 
an important role in human intestinal infection (37). Interestingly, 
it has recently been shown that Th17 differentiation in the small 
intestine is dependent on specific commensal flora (38). A single 
microbe, namely a segmented filamentous bacterium, was respon-
sible for inducing Th17 responses in the lamina propria of the small 
intestine (39). Colonization with this specific commensal resulted 
in increased Th17 responses, which were protective during ex-
perimental infection with C. rodentium (39).
Salmonella spp.
Salmonella enterica serotype Typhimurium can induce Th17 
responses in the intestinal mucosa in mice (40). Another study 
showed that Salmonella enterica serotype Typhimurium 
infection resulted in increased levels of IL-17, IL-22 and IL-23, 
and induction of MIP-2 and Lcn2 genes in the intestine (41). 
These responses were mainly driven by IL-23 (41). In the 
setting of IL-12 deficiency, IL-23 dependent IL-22 was shown 
to be crucial in protection against disseminated infection with 
Salmonella enterica serotype Enteritidis, while IL-17 was 
redundant in this model (42). However, it has also been 
shown that IL-17 deficient mice had slightly higher bacterial 
load in liver and spleen when compared to control mice in 
this model of disseminated Salmonella infection (42). During 
Salmonella enterica serotype Typhimurium infection, IL-17 
deficiency in mice resulted in impaired neutrophil recruitment 
to the intestinal mucosa (43). It has been reported that HIV- 
infected patients are more susceptible to non-typhoid Salmonella 
bacteremia (44). IL-17 deficiency caused by Simian immuno-
deficiency virus (SIV) in macaques, which is the primate 
variant of HIV, resulted in increased translocation of Salmonella 
enterica serotype Typhimurium (43). Interestingly, S. typhimurium 
infection in SIV positive macaques caused significant less IL-17 
and IL-22, whereas IFNγ production was normal. These data 
indicate that Th17 responses play an important role in controlling 
mucosal host defense against non-thyphoid Salmonella and 
protection against disseminated salmonellosis. In addition, S. 
enterica serotype Typhi can inhibit Th17 responses, which 
probably contributes to the higher virulence associated with 
this Salmonella spp. (40).
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Mycobacteria
M. bovis was one of the first microorganisms reported to in-
duce IL-17 production in CD4 positive T cells (21). In addition, 
dendritic cells that are stimulated with M. tuberculosis pro-
duce IL-12 and IL-23 (45). IL-23 was shown to be crucial for 
the induction of Th17 responses against M. tuberculosis and 
M. Bovis (46). IL-23 has also been shown to be important for 
M. tuberculosis-induced Th1 responses (45). Interestingly, it 
has been reported that when the IL-17A receptor is absent in 
mice, no difference in clearance of M. tuberculosis infection 
was observed compared to control mice (47). Th1 cells seem 
to be more important in the protection against primary M. tu-
berculosis infection, while the absence of Th17 cells does not 
alter protection against primary infection (48). These data are 
supported by the absence of mycobacterial infections in pa-
tients with hyperIgE syndrome. Although IL-17 does not ap-
pear to play a role in primary TB infection, it may play a role 
in the maintenance of the inflammatory response. In line with 
this, granuloma formation in the lungs of IL-17 deficient mice 
infected with BCG was reported to be impaired and IL-17 was 
shown to play a role in the trafficing of Th1 cells to the site of 
infection (49). These data suggest that Th17 responses play an 
important role in providing long lasting immunity against M. 
tuberculosis, and could therefore be crucial for vaccine devel-
opment against M. tuberculosis. 
Bordetella spp.
Although earlier studies have reported that B. pertussis in-
fection promotes the Th1 response (50), more recent studies 
have shown that B. pertussis is also able to skew the host re-
sponse towards a Th17 profile (51). Blocking of IL-17 during B. 
pertussis infection in mice resulted in reduced neutrophil re-
cruitment and modestly increased bacterial burden (51). In ad-
dition, B. pertussis toxin is able to induce IL-17 responses (52). 
B. bronchiseptica is also able to skew the immune response to-
wards a Th17 response (53). Interestingly, lung tissue from 
mice infected with B. bronchiseptica expressed a strong Th17 
response. It remains however to be established if Th17 re-
sponses contribute to host defense against Bordetella spp.
Other bacteria
Porphyromonas givinalis is an anaerobic bacterium which 
causes periodontal disease (PD). This is associated with perio-
dontal bone destruction. It has been reported that patients with 
severe PD have elevated IL-17 responses (54). Despite this ob-
servation and the observations that Th17 responses have been 
associated with bone destruction and the induction of Lyme ar-
thritis, it has been reported that the Th17 response induced by 
P. gingivalis infection prevented bone destruction in mice (55). 
In case of Mycoplasma pneumonia it has been reported that 
this pathogen triggered alveolar macrophages to produce 
IL-23, which subsequently contributed to an increase of IL-17 
production (56). Depletion of IL-23 resulted in less IL-17 pro-
duction and reduced lung neutrophil recruitment (56). 
However, Th17 responses during bacterial infection are not 
always beneficial for the host. Patients with cystic fibrosis (CF), 
which have defects in a chlorine channel which contributes to 
thick mucus production in the lungs (57), are more susceptible 
to Pseudomonas aeruginosa infection. CF patients with P. aeru-
ginosa infection had higher levels of the Th17 cytokines IL-23 
and IL-17 (58). An important observation made by others was 
that mice deficient in IL-23 showed decreased inflammation 
compared to wild type mice, although they had the same 
amount of P. aeruginosa dissemination (59). These data suggest 
that the Th17 response against P. aeruginosa does not play a 
crucial role in the host defense against this pathogen, but that it 
contributes to the pathology of the airways which leads to 
bronchiectasis seen in CF patients. It must however also be 
mentioned that IL-17 was recently shown to be a critical factor 
in a vaccine that induced protection to P. aeruginosa (60). 
Another study has shown that mice injected intraperitoneal 
with B. fragilis formed abscesses in an IL-17 dependant way, 
and that co-localization of IL-17 producing CD4 positive cells 
within the abscess wall was shown (61). Furthermore, when 
these mice were treated with an IL-17 neutralizing antibody, 
the formation of these abcesses was blocked. These studies sug-
gest that Th17 responses during certain types of bacterial in-
fections can result in deleterious host effects. 
Patients with hyperIgE syndrome are especially susceptible 
to S. aureus (6, 62-64). It has recently been reported that hu-
man keratinocytes and bronchial epithelial cells were espe-
cially dependent on Th17 cytokines for their anti-staph-
ylococcal host defense, such as secretion of chemokines that 
recruit neutrophils and the production of antimicrobial pep-
tides (64). In addition, an association between the severity of 
the defective Th17 response against S. aureus and the suscepti-
bility to S. aureus pneumonia has been reported (van de 
Veerdonk et al. in press). Three patients with a STAT3 muta-
tion and hyperIgE syndrome that had a partial S. aureus-in-
duced IL-17 deficiency, never developed S. aureus pneumonia 
in contrast to patients with a complete deficiency in S. aureus 
induced IL-17.
Finally, studies that investigated the role of IL-17 in anti-
bacterial host defense have also provided insights in the role of 
IL-17 production by innate immune cells such as γδ T-cells. γδ 
T-cells rather than CD4 T helper cells were found to be the 
main source of IL-17 during mycobacteria infection in mice 
(65). This was further supported by the observation that pa-
tients with TB had higher proportions of γδ T-cells that were 
able to produce IL-17 in their peripheral blood compared to 
healthy controls (66). In addition, it has been shown that IL-17 
mediates protection against Listeria monocytogenis in the liver 
(67, 68) and this IL-17 production was mainly derived from γδ 
T-cells (67, 68). Similar findings were reported for Escherichia 
coli in a mouse model of intraperitoneal infection (69), where 
neutrophils were shown to infiltrate in an IL-17 dependant 
manner and interestingly and γδ T-cells were the major source 
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for IL-17 (69). These observations suggest that innate immune 
cells are also an important source of IL-17 during bacterial in-
fections and supports the hypothesis that IL-17 producing γδ 
T-cells are able to provide an efficient first line of defense 
against bacterial invasion (70).
Th17 responses in viral infections
Viruses
It is generally accepted that antiviral host defense is mainly 
mediated through the production of type 1 IFN and IFNγ. Th1 
responses have clearly been associated with protective host 
defense against viruses. Since there were no suggestions that 
STAT3 deficient patients were more susceptible to viral in-
fections, it may be hypothesized that Th17 responses played a 
minor role in antiviral host defense and that Th1 and type I in-
terferon responses are the main protective adaptive immune 
response against viral infection. However, recent evidence 
suggests that viruses can also induce Th17 cells, although their 
role in antiviral host defense still remains to be elucidated. 
Vaccinia virus
Smallpox, which represents a serious threat as a possible agent 
for bioterrorism, has been eradicated by the smallpox vaccine 
that consists of live vaccinia virus (VV). One of the first reports 
that studied the role of IL-17 in viral infection was from Patera 
et al. They inserted murine IL-17 into vaccinia virus (VV-IL-17) 
and showed that VV-IL-17 was much more virulent than wild 
type VV (71). Mice infected with VV-IL-17 had higher viral 
burdens and had impaired NK cell cytotoxicity. In contrast, an-
other study reported that VV-IL-17 was less virulent than 
VV-WT in mice, and IL-17-deficient mice were more sensitive 
to VV-WT than control mice (72). In addition, VV expressing 
IL-23 were shown to be less virulent than wild type VV (72). 
This controversy still has to be addressed in additional studies. 
In patients with atopic dermatitis, VV vaccination can result 
in eczema vaccinatum, which is a disseminated form of vacci-
nia infection and can be lethal. Recently, two reports showed 
an immunopathological role for IL-17 in eczema vaccinatum 
(73, 74). IL-17 was shown to reduce NK activity in mice with 
atopic dermatitis, resulting in higher susceptibility to eczema 
vaccinatum (73). Similar results were obtained by eliciting Th2 
responses using ovalbumin, thereby simulating allergic skin in-
flammation (74). After VV inoculation, mice with sensitized 
skin showed localized IL-17 expression, increased IL-23, IL-6 
levels and neutrophil influx, which resulted in increased viral 
loads in the skin and organs when compared with mice that 
had unsensitized skin (74). Moreover, IL-17 neutralization us-
ing anti-IL-17 showed decrease of lesions and viral load while 
IL-17 administration promoted viral replication. In conclusion, 
these data suggest that IL-17 contributes to viral replication in a 
model of disseminated vaccinia infection rather than providing 
host defense against viral infection, and suggests that IL-17 is a 
potential target during disseminated vaccinia virus infection.
Theilers murine encephalomyelitis virus
Theilers murine encephalomyelitis virus (TMEV) infects micro-
glial cells, oligodendrocytes, astrocytes and macrophages in 
the central nervous system of mice, thereby inducing demye-
lating disease. In response to TMEV, macrophages are able to 
produce IL-23p19 and IL-12p40 (75). Recently, it has been 
shown that Th17 cells promote chronic viral infection in an ex-
perimental TMEV infection model, and play an important role 
in demyelinating disease. IL-17 was responsible for the in-
duction of anti-apoptotic mechanisms that resulted in the sur-
vival of cells infected with TMEV (76). Blocking IL-17 resulted 
in more efficient clearance of TMEV and cytotoxic T cell re-
sponses and could prevent disease development. It has been 
proposed that IL-17 could be a potential therapeutic target in 
chronic diseases associated with viral infections. 
Herpes simplex virus
An important complication of Herpes simplex virus infection 
(HSV) is damage to the cornea, also called herpetic stromal 
keratitis. It has been shown that patients with corneal HSV in-
fection have increased levels of local IL-17, which can bind to 
IL-17R on corneal fibroblasts (77). This triggers expression of 
the neutrophil attracting chemokines IL-8 (CXCl-8) and 
MMP-1, which can subsequently result in neutrophil influx 
and inflammation that causes damage to the cornea and even-
tually blindness. In addition, mice lacking the IL-17R have de-
creased neutrophilic migration in the cornea and corneal path-
ology, although this effect was transient and control of viral 
growth in the cornea was not affected in IL-17R-/- mice (78). 
However, it has also been proposed that the immunopathol-
ogy in herpetic stromal keratitis is mainly driven by Th1 re-
sponses and not Th17 responses (79). 
Human immunodeficiency virus
Interestingly, early HIV infection is associated with an increase 
of IL-17 production by CD4 positive and CD4 negative cells in 
peripheral blood (80). Misse et al. have proposed that IL-22 
contributed to antiviral defense by activating acute-phase pro-
teins and induction of IL-22 might be a protective mechanism 
during HIV infection (81). Although Th17 responses could 
have a protective role against HIV infection, HIV infection has 
mainly provided supporting evidence of the role of CD4 pos-
itive T cells during specific infections. This is due to the fact 
that HIV specifically infects CD4 positive T helper cells, which 
results in a depletion of CD4 positive IL-17 producing cells in 
humans in vivo. The observation that HIV patients are espe-
cially susceptible to oropharyngeal C. albicans infection sup-
ports the important role for CD4 positive cells that secrete 
IL-17 in anti-Candida host defense. Furthermore, the increased 
susceptibility to non-typhiod salmonella infections underscores 
the important role for Th17 cells in the protection against 
non-typhoid Salmonella spp. 
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Hepatitis viruses
It has been shown that during hepatitis C infection virus specif-
ic Th17 cells are induced (82). However, hepatitis C also in-
duces immunosuppressive cytokines IL-10 and TGF-β, which 
are able to inhibit Th17 and Th1. Neutralization of TGF-β has 
been shown to increase IL-17 production in response to hep-
atitis C nonstructural protein 4 (82). In patients with chronic 
hepatitis B, Th1 cells were decreased and Th17 cells were in-
creased (83). The Th17 cytokine IL-22 was shown to be pro-
tective, however a protective function for IL-17 was not ob-
served (84). The balance between Th1 and Th17 seems to play 
an important role in viral hepatitis, although it remains to be 
elucidated if Th17 responses favor protective host defense. 
Other viruses
Several other studies have shown that IL-17 is elevated during 
viral infection: when mice that are deficient in Th1 responses 
are infected with lymphocytic choriomeningitis viral infection, 
they display elevated IL-17 producing CD8 T cells and devel-
op progressive inflammation (85). Human T-cell leukemia vi-
rus (HTLV) was shown to up-regulate IL-17 expression in CD4 
T-cells (86). In studies where epithelial cells were exposed to 
human rhinovirus, increased induction of IL-17 was shown, to-
gether with specific infiltration of neutrophils in the lungs (87). 
It was however not clear in these studies whether IL-17 pro-
vides a protective antiviral role or whether it contributes to in-
flammation that is detrimental for the host. Notably, Th17 re-
sponses were shown to be protective in IL-10 deficient mice 
infected with Influenza virus (88).
Th17 responses in parasite infections
Protozoa
Evidence regarding the role of Th17 responses in the host de-
fense against protozoa is relatively limited. IL-4 which is the 
prototypical effector cytokine of Th2 cells can negative regulate 
Th17 responses (2), and therefore it may be hypothesized that 
Th17 responses would not be strongly involved in host defense 
against parasites. However, new studies have suggested a more 
subtle view. Oral Toxoplasma gondii infection in IL-17 defi-
cient mice leads to higher mortality than in control mice (89). 
These mice were shown to have less parasite burden and nor-
mal neutrophil infiltration during T. gondii infection (89). 
Despite the beneficial effect of IL-17 mediated inflammation 
which effectively cleared T. gondii infection, increased liver 
and intestinal pathology was observed. Stumhofer et al, have 
shown that IL-27 deficient mice show a profound Th17 re-
sponse and severe neuroinflammation (90). These data indicate 
that Th17 responses can contribute to persistent inflammation 
in the organs affected by Toxoplasma. Furthermore, IL-27 
which suppresses Th17 responses was found to be beneficial in 
infections with the protozoan Trypanosoma cruzi (91). In an 
experimental model of Leishmania infection, IL-17 and IL-22 
were shown to be important in the protection against L. dono-
vani (92), but in L. major infection IL-27 was shown to inhibit 
Th17 responses and this prevented immunopathology (93). 
These data suggest that the inhibiting effect of IL-27 during in-
fection with protozoa is of utmost importance to control the 
Th17 responses that contribute to persistent inflammation. 
Mice deficient in bradykinin receptor 2 were shown to have 
higher Th1 responses at the cost of lower Th17 responses, and 
were better protected against intraperitoneal T. cruzi infection 
than control mice, which provides further evidence that Th17 
responses can be detrimental for the host during protozoal in-
fection (94). However, it must be mentioned that a study on 
Leishmania braziliensis showed protection that was mediated 
by IFN-γ and IL-17 producing T-cells (95). 
Helminths
Infection with Schistosoma mansoni in mice causes develop-
ment of hepatic granuloma around the S. mansoni eggs (96). 
Antigens from these parasite eggs have been shown to cause 
CD4 positive T-cell mediated immunopathology. IL-12p40 de-
ficient mice not able to make IL-12 and IL-23 were completely 
resistant to immunopathology (96), while mice with IL-12p35 
deficiency that are not capable of making IL-12 still showed se-
vere immunopathology. In addition, IL-17 neutralization sig-
nificantly reduced immunopathology observed in S. mansoni 
infection (96, 97). Despite this immunopathological role for 
Th17 responses in S. mansoni infection, it has also been 
shown that TGF-β can up-regulated Th17 responses which re-
sult in increased resistance against lung-stage schistosomula 
(98). Evidence for a negative role for Th17 was also described 
during infection with Trichuris muris, which is the murine var-
iant of Trichuris trichuria. Down-regulation of the Th2 promot-
ing cytokine IL-25 caused severe inflammation associated with 
high levels of IFN-γ and IL-17, although it still remains to be 
elucidated which cytokine contributed most substantial to 
these effects (99). In general, these observations suggest that 
Th17 responses in the setting of parasitic infections can con-
tribute to host defense, but they have to be controlled, for ex-
ample by cytokines such as IL-27, in order to prevent 
immunopathology.
Th17 responses in infection: the balance between 
protection and immunopathogenesis
Both pathological and protective roles have been described 
with respect to the Th17 lineage in infectious diseases (Table 
1). In infections caused by bacteria and fungi, the pathogen in-
duced Th17 response has been reported as an important medi-
ator of protective mucosal host defense. Th17 cells improve 
mucosal barrier function during infection by secretion of an-
ti-microbial peptides and additional chemokine signaling for 
neutrophil reinforcements. The importance of the Th17 subset 
in mucosal host defense is underscored by the observation that 
patients with hyperIgE syndrome and chronic mucocutaneous 
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Pathogen Infection Th17 response
Fungi
Candida albicans
Aspergillus fumungatus
Pneumocystis carinii
Cryptococcus neoformans
Paracoccidioides braziliensis
Systemic
Mucosal
Intra gastric 
Intranasal
Pulmonary
Pulmonary
Brain
Pulmonary
Increased susceptibility in IL-17RA deficient mice (7)
Deficient Th17 response in humans and mice leads to increased susceptibility to candidiasis
  (6, 11, 63, 64)
IL-17 deficiency  increases susceptibility to oropharyngal candidiasis in mice (8) 
Th17 responses are detrimental to the host (10)
IL-23 deficiency reduces fungal burden, IL-17 inhibits protectiveTh1 responses (9)
Deficient ROS results in increased Th17 responses detrimental for the host (17)
IL-17 neutralization increases disease severity (18)
IL-23 deficiency leads to impaired IL-17 expression and higher mortality in mice (19)
Mice deficient for TLR2 show increased protective Th17 responses (20)
Bacteria
Borrelia burgdorferi
Helicobacter pylori
Klebsiella pneumoniae
Salmonella enterica
  Typhimurium
Salmonella enterica
  Enteritidis
Salmonella enterica Typhi
Mycobacterium bovis BCG
Mycobacterium tuberculosis
Bordetella pertussis
Bacteroides fragilis
Porphyromonas givinalis
Pseudomonas aeruginosa
Mycoplasma pneumoniae
Citrobacter rodentium
Listeria monocytogenis
Escherichia coli
Staphylococcus aureus
Haemophilus influenzae
Synovium
Gastric
Pulmonary
Intestinal mucosa
Intestinal mucosa
Intestinal mucosa
Pulmonary
Pulmonary
Pulmonary
Abdominal
Periodontal
Pulmonary
Pulmonary
Intestinal mucosa
Liver
Intra peritoneal
Epithelium
  (lung, skin)
Pulmonary
Neutralization of Th17 responses prevents Borrelia induced arthritis (25)
STAT3 induction resulting  in sustained IL-17 expression and persistent inflammation (27)
Th17 deficiency leads to lethal infection in mice, IL-17 administration restores normal host
  defence (30, 32)
Induction of AMPs by Th17 cytokines IL-17 and IL-22  (33, 34)
IL-17 deficiency results in impaired neutrophil recruitment (43)
IL-22 crucial in protection against dissemination of infection (42)
IL-17 deficiency causes higher bacterial load in liver and spleen (42)
viaB capsule encoding locus inhibits IL-17 expression (40)
Induction of IL-17 expression in CD4 T cells (21)
IL-23 crucial for Th17 response (46)
IL-17RA deficiency gives no difference in bacterial clearance (47) 
Host response is skewed towards Th17 response and neutralization of IL-17 before challenge
  showed reduced vaccine protection (51)
Pertussis toxin induces IL-17 responses (52)
IL-17 is associated with abscess formation (61)
Elevated IL-17 in patients with severe PD (54)
Th17 responses prevent bone destruction in mice (55)
High levels of IL-23 and IL-17 associated with severe inflammation during infection in CF
  patients (58)
IL-23 deficiency causes decreased inflammation but unchanged bacterial dissemination in CF
  mice (59)
IL-17 critical in vaccine induced protectivity (60)
IL-23 depletion results in reduced neutrophil recruitment in mice (56)
Reduced survival rates in IL-23 deficient mice (35)
Induction of AMPs by Th17 responses in mice (36, 37)
IL-17 contributes to protection, mainly derived from γδ T-cells (67, 68)
IL-17 contributes to protection, mainly derived from γδ T-cells (69)
Deficient Th17 response in humans and mice leads to increased susceptibility infection
  (6, 62-64)
Induction of AMPs by Th17 responses in mice (36)
Deficient Th17 response in humans and mice leads to increased susceptibility infection (62)
Virusses
Vaccinia virus
Theilers murine
  encephalomyelitis virus
Herpes simplex virus
Human immunodeficiency
  virus
Hepatitis B virus
Rhino virus
Influenza virus
Skin
Brain
Eye
Systemic
Liver
Pulmonary
localized Th17 responses are associated with increased viral loads (74)
IL-17 contributed to viral persistence (76)
IL-17R deficient mice have less corneal pathology but unaffected viral growth (78)
Increased IL-17 production in early HIV infection (80)
Induction of acute-phase proteins by IL-22 (81)
Chronic hepatitis show increased Th17 and decreased Th1 responses (83)
IL-22 is protective in conA induced hepatitis (84)
Increased induction of Th17 and pulmonary neutrophil infiltration (87)
Protective Th17 responses in IL-10 deficient mice (88)
Parasites
Toxoplasma gondii
Trypanosoma cruzi
Cryptosporidum parvum
Leishmania braziliensis
Leishmania donovani
Leishmania major
Schistosoma mansoni 
Trichuris muris
Intestinal
Brain
Systemic
Intestinal
Systemic
Systemic
Systemic
Liver
Lung
Intestine
IL-17 contributes to host defense, but also inflammatory damage (89)
IL-27 deficiency results in higher Th17 responses and neuroinflammation (90)
IL-27 mediated suppression of Th17 responses is beneficial (91)
IL-23 and IFN-γ reduced parasite shedding (100)
Protection by IFN-γ and Th17 producing T-cells (95)
IL-22 and IL-17 shown to be protective (92)
Less pathology when Th17 response is inhibited by IL-27 (93)
Less Th17 responses resulted in absence of pathology (96, 97)
TGF-β mediated upregulation of Th17 responses resulted in protection (98)
Downregulation of Th2 responses resulted in immunopathology through Th1 and Th17
  responses (99)
Table 1. Overview regarding the role of Th17 responses in relation to viral, bacterial, fungal and parasitic infections
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Fig. 2. Th17 responses in infection: the balance between protection
and immunopathogenesis. Th17 responses are important for the host 
defense against extracellular bacteria and fungi by orchestrating neu-
trophil recruitment and stimulating antimicrobial peptides (AMPs). 
However, Th17 responses can also contribute to chronic inflammation
and can be favorable for the pathogen, as has been shown for para-
sites and viruses.
candidiasis suffer from a severe form of mucosal candidiasis 
and they display specific defects in their Th17 response against 
C. albicans. 
However, in viral infections and parasitic infections the role 
of Th17 responses is less clear and IL-17 has even been re-
ported to be detrimental for the host. Interestingly, Th17 re-
sponses inhibit apoptosis of virus infected cells and contribute 
to persistence of the virus. In parasitic infections IL-17 was 
shown to contribute to persistent inflammation. Since Th17 
cells are associated with autoimmune diseases and hence 
chronic inflammation, it seems logical that persistent and 
chronic induction of Th17 responses, triggered by pathogens 
that are not sufficiently cleared, can result in immunopathol-
ogy that is detrimental for the host. 
Th17 responses can effectively recruit and orchestrate neu-
trophil activation, and therefore are probably very efficient in 
inducing the killing of extracellular invading pathogens, while 
the killing and clearance of intracellular pathogens such as vi-
ruses may be more efficient in the setting of a strong Th1 re-
sponse, and host defense against parasitic infection requires an 
optimal Th2 response. Since skewing towards Th17 responses 
can result in downregulation of Th1 and possibly Th2 re-
sponses, Th17 cells might in this way contribute to a sub-
optimal host defense against viruses and parasites (Fig. 2). 
Although Th17 cells have only recently been discovered, they 
have already provided crucial insights into the host defense 
against microorganisms. Understanding the Th17 responses 
and their interactions with the immune repertoire will likely 
provide crucial insights in the host defense and immune re-
sponses, and this will provide new tools for the development 
of effective immunomodulatory treatment strategies in the set-
ting of infectious diseases. 
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